Diabetes News and Research

Latest Diabetes News and Research

New study reveals better treatment options for proliferative diabetic retinopathy

This National Diabetes Month, there is some good news for people with eye complications from diabetes. Earlier this month, a network of researchers supported by the National Eye Institute (NEI) found that the drug Lucentis (ranibizumab) can be highly effective for treating proliferative diabetic retinopathy, an eye disease that can occur as a complication of diabetes.

20 Nov 2015

Type II diabetes drug can effectively clear fatty liver disease from some patients

New research published in The Lancet has shown that a drug, currently used in the treatment of Type II diabetes, can be effective in clearing fatty liver disease from some patients.

20 Nov 2015

BUSM researchers identify new fingerprint of inflammation in obesity-associated type 2 diabetes

There is strong evidence that inflammation promotes obesity-associated type 2 diabetes and diabetes complications. However, clinical trials with anti-inflammatory drugs have only been modestly effective for treating Type 2 diabetes. A new fingerprint of inflammation that may be able to predict which patients with obesity may also develop type 2 diabetes has been identified by Boston University School of Medicine researchers.

19 Nov 2015

Study provides insight into the structure of dark proteome

Proteins are often referred to as the building blocks of life, and make up about 15 per cent of the mass of the average person, performing a wide variety of essential functions in the body.

19 Nov 2015

Global tissue engineered medical devices market expected to cross US$ 26 billion by 2020

According to recently published Pharmaion report, "Global Tissue Engineered Medical Devices Market Forecast & Opportunities, 2020", global tissue engineered medical devices market is anticipated to cross US$ 26 billion by 2020.

19 Nov 2015

Lilly, Merck expand oncology clinical trial collaboration

Eli Lilly and Company and Merck, known as MSD outside the United States and Canada, today announced the extension of an existing collaboration to evaluate the safety and efficacy of the combination of Lilly's ALIMTA (pemetrexed for injection) and Merck's KEYTRUDA (pembrolizumab) in a pivotal Phase III study in first-line nonsquamous non-small cell lung cancer (NSCLC).

19 Nov 2015

Consuming tree nuts may reduce risk of cardiovascular disease, new study finds

A new study published in the American Journal of Clinical Nutrition found that consuming tree nuts, such as walnuts, may lower the risk of cardiovascular disease. After conducting a systematic review and meta-analysis of 61 controlled trials, one of the authors, Michael Falk, PhD, Life Sciences Research Organization, found that consuming tree nuts lowers total cholesterol, triglycerides, LDL cholesterol, and ApoB, the primary protein found in LDL cholesterol.

19 Nov 2015

Sildenafil drug improves insulin sensitivity in people at risk for diabetes

The drug sildenafil, sold as Viagra and other brand names, improves insulin sensitivity in people at risk for diabetes, researchers at Vanderbilt University Medical Center reported today.

19 Nov 2015

New insulin pill shows promise as novel form of therapy for diabetes

An insulin pill being developed by researchers at UC Santa Barbara may in the near future give another blood sugar management option to those who suffer from diabetes. The novel drug delivery technology may also apply to a wide spectrum of other therapies.

19 Nov 2015

IQWiG finds no added benefit for insulin degludec/liraglutide in adults with type 2 diabetes

The fixed combination of the two drugs insulin degludec and liraglutide (trade name: Xultophy) has been approved since June 2015 also in adults with type 2 diabetes mellitus when oral antidiabetics (OADs) combined with a GLP-1 receptor agonist do not provide adequate glycaemic control. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether this fixed combination offers an added benefit over the appropriate comparator therapy (ACT).

19 Nov 2015

Potential treatment strategy for glycogen storage disease

Researchers from the Duke-NUS Graduate Medical School Singapore and Duke Medicine have identified a potential treatment strategy for an often-fatal inherited glycogen storage disease.

18 Nov 2015

Coordinated care and telehealth deployment ‘cookbook’ debuted

Royal Philips and its ACT-program consortium partners today announced the debut of a ‘cookbook’ outlining key enablers necessary to scale connected care and telehealth programs.

18 Nov 2015

Exercise, healthy lifestyle habits may cut prostate cancer risk by up to 68%

A study that tracked tens of thousands of midlife and older men for more than 20 years has found that vigorous exercise and other healthy lifestyle habits may cut their chances of developing a lethal type of prostate cancer by up to 68 percent.

18 Nov 2015

Scientists succeed in promoting regeneration of injured neurons in zebrafish by the use of light

The nervous system is built to last a lifetime, but diverse diseases or environmental insults can overpower the capacity of neurons to maintain function or to repair after trauma. A team led by Dr. Hernán López-Schier, head of the Research Unit Sensory Biology and Organogenesis at Helmholtz Zentrum München, now succeeded in promoting the repair of an injured neural circuit in zebrafish.

18 Nov 2015

Elite endurance athletes who eat few carbohydrates burn more fat during prolonged exercise

Elite endurance athletes who eat very few carbohydrates burned more than twice as much fat as high-carb athletes during maximum exertion and prolonged exercise in a new study - the highest fat-burning rates under these conditions ever seen by researchers.

18 Nov 2015

Researchers identify a mechanism that may explain association between obesity and cancer

Researchers have identified a mechanism that allows cancer cells to respond and grow rapidly when levels of sugar in the blood rise. This may help to explain why people who develop conditions in which they have chronically high sugar levels in their blood, such as obesity, also have an increased risk of developing certain types of cancer.

18 Nov 2015

Simple microRNA sensor holds promise for prognosis, treatment of pancreatic and other cancers

A simple, ultrasensitive microRNA sensor developed and tested by researchers from the schools of science and medicine at Indiana University-Purdue University Indianapolis and the Indiana University Melvin and Bren Simon Cancer Center holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.

18 Nov 2015

Gestational diabetes mellitus screening provides more health benefits to pregnant women

A local research study conducted by KK Women's and Children's Hospital and Duke-NUS Graduate Medical School has found that pregnant patients benefit most from gestational diabetes mellitus (GDM) screening as it allows for timely interventions and brings about health benefits that far outweigh the cost.

18 Nov 2015

Vitamin E shows same efficacy in diabetic and nondiabetic patients

There have been numerous studies on the safety and efficacy of using vitamin E to treat nondiabetic patients with nonalcoholic steatohepatitis (NASH), but researchers at the annual meeting of the American Association for the Study of Liver Diseases presented results of vitamin E in diabetic and nondiabetic patients.

17 Nov 2015

Viking submits IND application to FDA to conduct VK2809 Phase 2 study in patients with LDL-C and fatty liver disease

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders, today announced that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration to conduct a Phase 2 study of VK2809 in patients with hypercholesterolemia and fatty liver disease.

17 Nov 2015

Diabetes News and Research

Latest Diabetes News and Research

New study reveals better treatment options for proliferative diabetic retinopathy

Type II diabetes drug can effectively clear fatty liver disease from some patients

BUSM researchers identify new fingerprint of inflammation in obesity-associated type 2 diabetes

Study provides insight into the structure of dark proteome

Global tissue engineered medical devices market expected to cross US$ 26 billion by 2020

Lilly, Merck expand oncology clinical trial collaboration

Consuming tree nuts may reduce risk of cardiovascular disease, new study finds

Sildenafil drug improves insulin sensitivity in people at risk for diabetes

New insulin pill shows promise as novel form of therapy for diabetes

IQWiG finds no added benefit for insulin degludec/liraglutide in adults with type 2 diabetes

Potential treatment strategy for glycogen storage disease

Coordinated care and telehealth deployment ‘cookbook’ debuted

Exercise, healthy lifestyle habits may cut prostate cancer risk by up to 68%

Scientists succeed in promoting regeneration of injured neurons in zebrafish by the use of light

Elite endurance athletes who eat few carbohydrates burn more fat during prolonged exercise

Researchers identify a mechanism that may explain association between obesity and cancer

Simple microRNA sensor holds promise for prognosis, treatment of pancreatic and other cancers

Gestational diabetes mellitus screening provides more health benefits to pregnant women

Vitamin E shows same efficacy in diabetic and nondiabetic patients

Viking submits IND application to FDA to conduct VK2809 Phase 2 study in patients with LDL-C and fatty liver disease

Genomics - Industry Focus eBook (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Diabetes News and Research

Latest Diabetes News and Research

Genomics - Industry Focus eBook (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in